RCEL Jul 2024 10.000 call
| Previous close | 0.2300 |
| Open | 0.1000 |
| Bid | 0.0500 |
| Ask | 0.2500 |
| Strike | 10.00 |
| Expiry date | 2024-07-19 |
| Day's range | 0.1000 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 144 |
Simply Wall St.Institutions own 46% of AVITA Medical, Inc. (NASDAQ:RCEL) shares but retail investors control 50% of the company
Key Insights The considerable ownership by retail investors in AVITA Medical indicates that they collectively have a...
GlobeNewswireAVITA Medical Achieves Milestone with First Case Using RECELL GO
Joseph M. Still Burn Center at Doctors Hospital of Augusta first to treat a patient using AVITA Medical’s FDA-Approved RECELL GO System for thermal burn wounds and full-thickness skin defectsVALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M. Still Burn Center at Doctors Hospital of Augu
GlobeNewswireAVITA Medical Announces FDA Approval of RECELL GO
VALENCIA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for the RECELL GO™ System, its next-generation autologous cell harvesting device that harnesses the regenerative properties of a patient’s own skin to tre
